Close
Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
Show source BACK TO LIST

Laboratory Report

Patient
Name: Bertelsen, Bent
DOB: 12-SEP-1942 (Age: 82)
Gender: male
Address:
Bygget 41
340 14 Lagan (Sweden)
ID: 9943-935126-5
Report
Date: 29-APR-2023
Laboratory
Requested by
Värnamo sjukhus
331 56 Värnamo (Sweden)
Specimen
Collected: 28-APR-2023

Chemistry

Test 28 Apr 2023 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.4 H 4 - 6 %
Glucose [Mass/volume] in Blood 81.1 70 - 140 mg/dL
Urea nitrogen [Mass/volume] in Blood 18.3 7 - 45 mg/dL
Creatinine [Mass/volume] in Blood 0.7 L 0.8 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.3 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 142.7 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.7 3.5 - 5.3 mmol/L
Chloride [Moles/volume] in Blood 107.4 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 23.3 22 - 29 mmol/L

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows mildly elevated HbA1c, indicating suboptimal long-term glycemic control, suggestive of prediabetes or early diabetes. All other parameters, including renal function, electrolytes, and glucose, are within normal limits except for a slightly low creatinine, which is not clinically significant in this context. No acute laboratory abnormalities detected. Recommend monitoring glycemic control.